Radiation therapy (RT) quality assurance (QA) analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas (PDAC) Meeting Abstract


Authors: Tchelebi, L.; Smith, K. S.; Shi, Q.; Fitzgerald, T.; Chuong, M. D.; Zemla, T.; O'Reilly, E.; Meyerhardt, J.; Koay, E. J.; Leif, J. L.; Katz, M. H. G.; Herman, J.
Abstract Title: Radiation therapy (RT) quality assurance (QA) analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas (PDAC)
Meeting Title: 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2022)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 114
Issue: 3 Suppl.
Meeting Dates: 2022 Oct 23-26
Meeting Location: San Antonio, TX
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2022-11-01
Start Page: S105
End Page: S106
Language: English
DOI: 10.1016/j.ijrobp.2022.07.533
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 296 -- In section "Oral Scientific Sessions" -- Meeting was also held virtually -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    795 O'Reilly